Get the Stockscreener App
3.84
1.59%
0.06
Avita Medical Inc stock is traded at $3.84, with a volume of 31,306.
It is up +1.59% in the last 24 hours and down -30.69% over the past month.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$3.78
Open:
$3.68
24h Volume:
31,306
Relative Volume:
0.05
Market Cap:
$102.48M
Revenue:
$50.14M
Net Income/Loss:
$-35.38M
P/E Ratio:
-2.7429
EPS:
-1.4
Net Cash Flow:
$-39.46M
1W Performance:
+4.92%
1M Performance:
-30.69%
6M Performance:
-58.44%
1Y Performance:
-65.62%
1-Day Range:
$3.68
$3.91
1-Week Range:
$3.64
$4.02
52-Week Range:
$3.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
3.85 | 102.13M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
125.56 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.66 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
361.11 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.06 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.48 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
Historical volatility pattern of AVITA Medical Inc. visualizedWeekly Profit Analysis & Technical Pattern Recognition Alerts - newser.com
Is AVITA Medical Inc. stock a top pick in earnings seasonMarket Sentiment Report & Free Growth Oriented Trading Recommendations - newser.com
How AVITA Medical Inc. stock performs in interest rate cyclesProfit Target & Fast Exit/Entry Strategy Plans - newser.com
AVITA Medical Inc Stock Analysis and ForecastTop Performing Stocks & Backtest Your Strategy Before You Risk Money - earlytimes.in
How risky is AVITA Medical Inc. stock nowWatch List & Trade Opportunity Analysis - newser.com
Is it too late to sell AVITA Medical Inc.Market Movement Recap & Reliable Breakout Forecasts - newser.com
Why AVITA Medical Inc. stock remains a top recommendationQuarterly Investment Review & Safe Entry Momentum Tips - newser.com
AVITA Medical's RECELL System Highlights Clinical and Economic B - GuruFocus
Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment - Investing News Network
AVITA Medical (NASDAQ: RCEL) data show up to 97.55% donor site reduction with RECELL - Stock Titan
How AVITA Medical Inc. stock performs during Fed tightening cyclesGlobal Markets & Detailed Earnings Play Alerts - newser.com
How to escape a deep drawdown in AVITA Medical Inc.Trade Risk Assessment & Daily Volume Surge Trade Alerts - newser.com
How AVITA Medical Inc. stock performs in weak economyJuly 2025 Closing Moves & AI Powered Buy/Sell Recommendations - newser.com
Is AVITA Medical Inc. stock attractive for ETFsJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
How analysts rate AVITA Medical Inc. stock todayQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Using AI based signals to follow AVITA Medical Inc.2025 AllTime Highs & Free Daily Entry Point Trade Alerts - newser.com
Is AVITA Medical Inc. stock attractive for income investors2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com
Will AVITA Medical Inc. stock benefit from commodity prices2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com
Is AVITA Medical Inc. stock a buy for dividend growth2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Leading vs lagging indicators on AVITA Medical Inc. performanceTrade Analysis Report & AI Powered Buy/Sell Recommendations - newser.com
AVITA Medical, Inc. (RCEL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avita Medical gets FDA approval for ReCell skin regeneration device supplement - new.smallcaps.com.au
Published on: 2025-11-01 12:29:56 - newser.com
Avita Medical (RCEL) to Release Quarterly Earnings on Thursday - MarketBeat
Can AVITA Medical Inc. stock hit analyst price targetsRisk Management & Free High Accuracy Swing Entry Alerts - newser.com
Will AVITA Medical Inc. stock outperform Nasdaq index2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages AVITA Medical, Inc. (RCEL) Investors to Inquire about Securities Investigation - ACCESS Newswire
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):